Cargando…

Adapting SHIVs In Vivo Selects for Envelope-Mediated Interferon-α Resistance

Lentiviruses are able to establish persistent infection in their respective hosts despite a potent type-I interferon (IFN-I) response following transmission. A number of IFN-I-induced host factors that are able to inhibit lentiviral replication in vitro have been identified, and these studies sugges...

Descripción completa

Detalles Bibliográficos
Autores principales:	Boyd, David F., Sharma, Amit, Humes, Daryl, Cheng-Mayer, Cecilia, Overbaugh, Julie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4939950/ https://www.ncbi.nlm.nih.gov/pubmed/27399306 http://dx.doi.org/10.1371/journal.ppat.1005727

Ejemplares similares

Macaque interferon-induced transmembrane proteins limit replication of SHIV strains in an Envelope-dependent manner
por: Sharma, Amit, et al.
Publicado: (2019)

Several cell-intrinsic effectors drive type I interferon-mediated restriction of HIV-1 in primary CD4(+) T cells
por: Itell, Hannah L., et al.
Publicado: (2023)

Several cell-intrinsic effectors drive type I interferon-mediated restriction of HIV-1 in primary CD4(+) T cells
por: Itell, Hannah L., et al.
Publicado: (2023)

The Robust Restriction of Zika Virus by Type-I Interferon in A549 Cells Varies by Viral Lineage and Is Not Determined by IFITM3
por: Gobillot, Theodore A., et al.
Publicado: (2020)

Rational design and in vivo selection of SHIVs encoding transmitted/founder subtype C HIV-1 envelopes
por: O’Brien, Sean P., et al.
Publicado: (2019)

A virus-packageable CRISPR screen identifies host factors mediating interferon inhibition of HIV
por: OhAinle, Molly, et al.
Publicado: (2018)

Host cell glycosylation selects for infection with CCR5- versus CXCR4-tropic HIV-1
por: Itell, Hannah L., et al.
Publicado: (2023)

The TOP vector: a new high-titer lentiviral construct for delivery of sgRNAs and transgenes to primary T cells
por: Humes, Daryl, et al.
Publicado: (2020)

Adoption of an “Open” Envelope Conformation Facilitating CD4 Binding and Structural Remodeling Precedes Coreceptor Switch in R5 SHIV-Infected Macaques
por: Zhuang, Ke, et al.
Publicado: (2011)

Estimation of the in vivo neutralization potency of eCD4Ig and conditions for AAV-mediated production for SHIV long-term remission
por: Goyal, Ashish, et al.
Publicado: (2022)

Foamy Combinatorial Anti-HIV Vectors with MGMTP140K Potently Inhibit HIV-1 and SHIV Replication and Mediate Selection In Vivo
por: Kiem, Hans-Peter, et al.
Publicado: (2009)

HIV envelope antibodies and TLR7 agonist partially prevent viral rebound in chronically SHIV-infected monkeys
por: Moldt, Brian, et al.
Publicado: (2022)

Polyclonal HIV envelope-specific breast milk antibodies limit founder SHIV acquisition and cell-associated virus loads in infant rhesus monkeys.
por: Himes, Jonathon E., et al.
Publicado: (2018)

Variations in the Biological Functions of HIV-1 Clade C Envelope in a SHIV-Infected Rhesus Macaque during Disease Progression
por: Tso, For Yue, et al.
Publicado: (2013)

Mapping mutational effects along the evolutionary landscape of HIV envelope
por: Haddox, Hugh K, et al.
Publicado: (2018)

Antibody mediated protection of immunized macaques against pathogenic SHIV challenge
por: Srivastava, Indresh K, et al.
Publicado: (2006)

Complement contributes to antibody-mediated protection against repeated SHIV challenge
por: Goldberg, Benjamin S., et al.
Publicado: (2023)

Human Non-neutralizing HIV-1 Envelope Monoclonal Antibodies Limit the Number of Founder Viruses during SHIV Mucosal Infection in Rhesus Macaques
por: Santra, Sampa, et al.
Publicado: (2015)

Dynamics of Envelope Evolution in Clade C SHIV-Infected Pig-Tailed Macaques during Disease Progression Analyzed by Ultra-Deep Pyrosequencing
por: Tso, For Yue, et al.
Publicado: (2012)

Rhesus macaques vaccinated with consensus envelopes elicit partially protective immune responses against SHIV SF162p4 challenge
por: Eugene, Hermancia S, et al.
Publicado: (2013)

CTL-mediated immunotherapy can suppress SHIV rebound in ART-free macaques
por: Fan, Jin, et al.
Publicado: (2019)

Griffithsin carrageenan fast dissolving inserts prevent SHIV HSV-2 and HPV infections in vivo
por: Derby, Nina, et al.
Publicado: (2018)

Shiv Nadar School students visit CERN
por: Poulaillon, Jimmy, et al.
Publicado: (2023)

Oral Vaccination Approaches for Anti-SHIV Immunity
por: Velarde de la Cruz, Erandi, et al.
Publicado: (2021)

Structure/Function Studies Involving the V3 Region of the HIV-1 Envelope Delineate Multiple Factors That Affect Neutralization Sensitivity
por: Zolla-Pazner, Susan, et al.
Publicado: (2015)

Identification of interdependent variables that influence coreceptor switch in R5 SHIV(SF162P3N)-infected macaques
por: Zhuang, Ke, et al.
Publicado: (2012)

Maternal Envelope gp41 Ectodomain-Specific Antibodies Are Associated With Increased Mother-to-Child Transmission of Human Immunodeficiency Virus-1
por: Naiman, Nicole E, et al.
Publicado: (2020)

Multilineage polyclonal engraftment of Cal-1 gene-modified cells and in vivo selection after SHIV infection in a nonhuman primate model of AIDS
por: Peterson, Christopher W., et al.
Publicado: (2016)

The C3/465 glycan hole cluster in BG505 HIV-1 envelope is the major neutralizing target involved in preventing mucosal SHIV infection
por: Charles, Tysheena P., et al.
Publicado: (2021)

Antibody responses induced by SHIV infection are more focused than those induced by soluble native HIV-1 envelope trimers in non-human primates
por: van Schooten, Jelle, et al.
Publicado: (2021)

Identification of HIV-1 Envelope Mutations that Enhance Entry Using Macaque CD4 and CCR5
por: Roop, Jeremy I., et al.
Publicado: (2020)

Efficacy of silk fibroin biomaterial vehicle for in vivo mucosal delivery of Griffithsin and protection against HIV and SHIV infection ex vivo
por: Crakes, Katti R, et al.
Publicado: (2020)

Simian-Human Immunodeficiency Virus SHIV.C.CH505 Persistence in ART-Suppressed Infant Macaques Is Characterized by Elevated SHIV RNA in the Gut and a High Abundance of Intact SHIV DNA in Naive CD4(+) T Cells
por: Obregon-Perko, Veronica, et al.
Publicado: (2020)

Gp120 V5 Is Targeted by the First Wave of Sequential Neutralizing Antibodies in SHIV(SF162P3N)-Infected Rhesus Macaques
por: Jia, Manxue, et al.
Publicado: (2018)

In memory of a Legend: Dr. Shiv Shankar Gupta
por: Chandra, Dinesh
Publicado: (2013)

SHIVs, monkeys, and anti-HIV-1 neutralizing antibodies
por: Martin, Malcolm A
Publicado: (2013)

Prevention of SHIV transmission by topical IFN-β treatment
por: Veazey, Ronald S., et al.
Publicado: (2016)

The number and genetic relatedness of transmitted/founder virus impact clinical outcome in vaginal R5 SHIV(SF162P3N) infection
por: Tsai, Lily, et al.
Publicado: (2014)

Compromised NK Cell-Mediated Antibody-Dependent Cellular Cytotoxicity in Chronic SIV/SHIV Infection
por: He, Xuan, et al.
Publicado: (2013)

Delayed vaginal SHIV infection in VRC01 and anti-α4β7 treated rhesus macaques
por: Calenda, Giulia, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_kgcqkv43o32asohmkcgmq6tp8u